These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
477 related items for PubMed ID: 15766532
1. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS. Cell; 2005 Mar 11; 120(5):701-13. PubMed ID: 15766532 [Abstract] [Full Text] [Related]
2. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T, Kiliaan AJ, Kadish I. Neurobiol Dis; 2006 Sep 11; 23(3):653-62. PubMed ID: 16829076 [Abstract] [Full Text] [Related]
3. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Howlett DR, Richardson JC, Austin A, Parsons AA, Bate ST, Davies DC, Gonzalez MI. Brain Res; 2004 Aug 13; 1017(1-2):130-6. PubMed ID: 15261108 [Abstract] [Full Text] [Related]
7. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition. Flood DG, Lin YG, Lang DM, Trusko SP, Hirsch JD, Savage MJ, Scott RW, Howland DS. Neurobiol Aging; 2009 Jul 13; 30(7):1078-90. PubMed ID: 18053619 [Abstract] [Full Text] [Related]
9. Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice. Tan J, Town T, Crawford F, Mori T, DelleDonne A, Crescentini R, Obregon D, Flavell RA, Mullan MJ. Nat Neurosci; 2002 Dec 13; 5(12):1288-93. PubMed ID: 12402041 [Abstract] [Full Text] [Related]
10. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. Kandimalla KK, Wengenack TM, Curran GL, Gilles EJ, Poduslo JF. J Pharmacol Exp Ther; 2007 Aug 13; 322(2):541-9. PubMed ID: 17505020 [Abstract] [Full Text] [Related]
11. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice. Härtig W, Goldhammer S, Bauer U, Wegner F, Wirths O, Bayer TA, Grosche J. J Chem Neuroanat; 2010 Sep 13; 40(1):82-92. PubMed ID: 20347032 [Abstract] [Full Text] [Related]
15. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A, Döbeli H, Bohrmann B. Neuroscience; 2006 Dec 01; 143(2):461-75. PubMed ID: 17008022 [Abstract] [Full Text] [Related]
17. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Lorenzo A, Yuan M, Zhang Z, Paganetti PA, Sturchler-Pierrat C, Staufenbiel M, Mautino J, Vigo FS, Sommer B, Yankner BA. Nat Neurosci; 2000 May 01; 3(5):460-4. PubMed ID: 10769385 [Abstract] [Full Text] [Related]
18. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice. Hartmann J, Erb C, Ebert U, Baumann KH, Popp A, König G, Klein J. Neuroscience; 2004 May 01; 125(4):1009-17. PubMed ID: 15120860 [Abstract] [Full Text] [Related]